Media Inquiries
- 615-322-6397 Email
Latest Stories
- Q&A: Vanderbilt expert discusses new research on how the brain affects the way we perceive film
- Individuals ages 8-20 with and without Neurofibromatosis Type 1 needed for research study on reading disabilities
- Celebration honors staff and faculty who supported VERA implementation
- HR Employee Learning and Engagement summer series: ‘Psychological Safety Beyond the Buzzword’
- Global Vanderbilt: James Muchira: It gave me the leeway to experiment
Vanderbilt’s partnership with Deerfield Management, Ancora, is opening a new request for applications focused on rare genetic diseases in January 2021.
Faculty interested in this rolling submission-review opportunity are invited to attend an information session, “Accelerating the Commercialization of Transformative Biomedical Technologies with a Focus on Rare Genetic Diseases,” on Thursday, Jan. 21, at 10 a.m. CT. More information is available here.